Epimedium flavonoids improve cerebral white matter lesions by inhibiting neuroinflammation and activating neurotrophic factor signal pathways in spontaneously hypertensive rats
International Immunopharmacology · 2024-09 · 139 · 112683
DOI: 10.1016/j.intimp.2024.112683 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-09. Verfasst von Weipeng Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing, China; Beijing Geriatric Medical Research Center, Beijing Engineering…. Hauptthemen laut MEDLINE: Rats, Inbred SHR, Signal Transduction, Flavonoids, Epimedium. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
Cerebral small vessel disease (CSVD) is one of the most common nervous system diseases. Hypertension and neuroinflammation are considered important risk factors for the development of CSVD and white matter (WM) lesions. We used the spontaneously hypertensive rat (SHR) as a model of early-onset CSVD and administered epimedium flavonoids (EF) for three months. The learning and memorization abilities were tested by new object recognition test. The pathological changes of WM were assessed using magnetic resonance imaging, transmission electron microscopy (TEM), Luxol fast blue and Black Gold staining. Oligodendrocytes (OLs) and myelin basic protein were detected by immunohistochemistry. The ultrastructure of the tight junctions was examined using TEM. Microglia and astrocytes were detected by immunofluorescence. RNA-seq was performed on the corpus callosum of rats. The results revealed that EF could significantly improve the learning and memory impairments in SHR, alleviate the injury and demyelination of WM nerve fibers, promote the differentiation of oligodendrocyte precursor cells (OPCs) into mature OLs, inhibit the activation of microglia and astrocytes, inhibit the expression of p38 MAPK/NF-κB p65/NLRP3 and inflammatory cytokines, and increase the expression of tight-junction related proteins ZO-1, occludin, and claudin-5. RNA-seq analysis showed that the neurotrophin signaling pathway played an important role in the disease. RT-qPCR and WB results showed that EF could regulate the expression of nerve growth factor and brain-derived neurotrophic factor and their downstream related proteins in the neurotrophin signaling pathway, which might explain the potential mechanism of EF's effects on the cognitive impairment and WM damage caused by hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing, China; Beijing Geriatric Medical Research Center, Beijing Engineering Research Center for Nervous System Drugs, National Center for Neurolo…
- Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing, China; Department of Pharmacy, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi, China.
Zitieren
APA
Wei, W., Ma, D., Gu, L., Li, Y., Zhang, L., Li, L., & Zhang, L. (2024). Epimedium flavonoids improve cerebral white matter lesions by inhibiting neuroinflammation and activating neurotrophic factor signal pathways in spontaneously hypertensive rats. International Immunopharmacology, 139, 112683. https://doi.org/10.1016/j.intimp.2024.112683
Vancouver
Wei W, Ma D, Gu L, Li Y, Zhang L, Li L, et al. Epimedium flavonoids improve cerebral white matter lesions by inhibiting neuroinflammation and activating neurotrophic factor signal pathways in spontaneously hypertensive rats. International Immunopharmacology. 2024;139:112683. doi:10.1016/j.intimp.2024.112683
BibTeX
@article{Wei2024,
author = {Wei, Weipeng and Ma, Denglei and Gu, Lihong and Li, Yali and Zhang, Li and Li, Lin and Zhang, Lan},
title = {Epimedium flavonoids improve cerebral white matter lesions by inhibiting neuroinflammation and activating neurotrophic factor signal pathways in spontaneously hypertensive rats},
journal = {International Immunopharmacology},
year = {2024},
volume = {139},
pages = {112683},
doi = {10.1016/j.intimp.2024.112683}
}
EUVIMED